An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles privately for source information, while also receiving discount codes.
Thriving Trade on Social Networks
Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and assertions of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.
Some experts stated the popularity for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, advertising, and customer regulations, risking fines, legal action or imprisonment.
Platform Reaction and Content Removal
According to the social media company, the platform has removed problematic material and prohibited associated keywords and search suggestions. The company stated it was committed to maintaining the service secure and investing in enhancing compliance measures.
Digital Trading Activities
Investigations also found communities with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, populated with photos of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at home.
Within moments of entering one community, a vendor posted WhatsApp details, where the majority of transactions occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, health issues or previous experience.
Product Details and Pricing
Inside these groups, posts show dark colored packages with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram stated it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering substances they cannot confirm. Even if the research behind this drug is valid, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.
Her team has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet authorized … may subject patients to possibly significant medical dangers”.
